The results of the Western blot analysis indicated that there was no significant alteration in the expression levels of CDC25A, CDK4, CDK6, and CDK2 in CRC cells after treatment with cynaroside and CDC25A silencing (Supplementary Materials Figure S1C). This evidence concerns the gene CDK2 and colorectal carcinoma.